Oregon Becomes First State To Legalize Psychedelic Mushrooms

Oregonians have voted to pass Measure 109 to become the first state in the country to legalize psilocybin. OregonLive reports: Measure 109 was passing by 59.25% Tuesday when the polls closed in Oregon. Multiple cities have decriminalized the substance, but Oregon will become the first to permit supervised use statewide if that majority holds. The measure […] will allow regulated use…

What if a Medical Treatment Could Change Your Political Or Religious Beliefs?

A research fellow at the University of Oxford’s Wellcome Centre for Ethics and Humanities writes in Scientific American: How would you feel about a new therapy for your chronic pain, which — although far more effective than any available alternative — might also change your religious beliefs? Or a treatment for lymphoma that brings one in three patients into remission, but…

Psychedelic drug psilocybin tamps down brain’s ego center

To see how psychedelics impact the claustrum, a mysterious region of the brain believed to control the ego, researchers compared the brain scans of people after they took psilocybin with their scans after taking a placebo. Source: https://www.sciencedaily.com/releases/2020/06/200605121512.htm

What it’s like to trip on psilocybin for a scientific research study

The psychoactive compound psilocybin may hold promise for treating depression, but how do we know it’s safe? Sam Wong volunteered for a study to find out Source: https://www.newscientist.com/article/2230189-what-its-like-to-trip-on-psilocybin-for-a-scientific-research-study/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home…

Psilocybin For Major Depression Granted Breakthrough Therapy By FDA

An anonymous reader quotes a report from New Atlas: The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD). This new FDA Breakthrough Therapy approval focuses on a seven-site, Phase 2 trial currently…

FDA Calls Psychedelic Psilocybin a ‘Breakthrough Therapy’ for Severe Depression

The FDA is helping to speed up the process of developing and approving a drug based on psilocybin, a hallucinogenic substance in magic mushrooms, to treat depression. Source: https://www.livescience.com/psilocybin-depression-breakthrough-therapy.html

Mindfulness meditation enhances positive effects of psilocybin

Recent years have seen a renewed interest in the clinical application of classic psychedelics in the treatment of depression and anxiety disorders. Researchers have now shown that mindfulness meditation can enhance the positive long-term effects of a single dose of psilocybin, which is found in certain mushrooms. Source: https://www.sciencedaily.com/releases/2019/10/191024075003.htm

Magic Mushrooms Can Help Smokers Kick the Habit

An anonymous reader quotes a report from NPR: New research shows that psilocybin might be an effective treatment for diseases such as depression and addiction. While the work is still in its early stages, there are signs that psilocybin might help addicts shake the habit by causing the brain to talk with itself in different ways. “These brain changes lead to,…